Fulgent Therapeutics
About:
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Website: https://www.fulgentgenetics.com/
Twitter/X: FulgentInfo
Description:
Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). Apart from traditional single gene tests, Fulgent Therapeutics has been investing heavily in the future. Using Next Generation Sequencing (NGS) technology we are developing a new series of panel based tests for our clients.
Total Funding Amount:
$34.8M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Temple City, California, United States
Founded Date:
2011-01-01
Contact Email:
info(AT)fulgent-therapeutics.com
Founders:
Ming Hsieh
Number of Employees:
1001-5000
Last Funding Date:
2016-05-24
IPO Status:
Public
Industries:
© 2025 bioDAO.ai